Tcg Advisory Services, LLC Eli Lilly & CO Call Options Transaction History

Tcg Advisory Services, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $77,214 - $96,002	100 Added 25.0%	500 $442,000
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $1.67 Million - $2.09 Million	-2,300 Reduced 85.19%	400 $362,000
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $4.03 Million - $5.39 Million	-6,800 Reduced 71.58%	2,700 $2.1 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $472,671 - $557,217	900 Added 10.47%	9,500 $5.54 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $3.74 Million - $5.15 Million	8,600 New	8,600 $4.62 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $6.43 Million - $7.49 Million	20,000 New	20,000 $7.32 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Tcg Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Tcg Advisory Services, LLC with notifications on news.